The company's IPO follows a $182m Series C funding round last year.

And then you had multiple mechanisms of action and multiple scaffolds ... In that case, it took seven years to get in 2012 to TRIKAFTA. I'm not saying it will happen that fast, but nonetheless ...

Neither Trikafta nor Alfytrek address NBD1 ... desire for more treatment options for CF patients, support for a new mechanism of action that could provide clinically meaningful benefit for ...

Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic fibrosis (CF), which offer a different mechanism to those sold by market ...

Orphan Medicines, led by the gene therapy Zolgensma and the Cystic Fibrosis treatment Trikafta were the most successful launches according to IQVIA list price sales data in Europe in 2020 (figure 2).

EU countries have agreed on a market correction mechanism which will limit episodes of extraordinarily high gas prices in the EU and thus reduce the impact of price hikes on citizens and the economy.

The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial intelligence (AI), market demand, and favorable regulatory support. Companies ...

My CF consists of two very rare genetic mutations. We had all heard of Trikafta being around the corner, but I had been told so many times that it wasn’t designed for someone with my mutations. So, ...